QR Code

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Enregistré dans:
Auteurs principaux: Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2023-01-01
Collection:Frontiers in Oncology
Sujets:
SMAC mimetics
LCL161
Gemcitabine plus Cisplatin therapy
multidrug resistance
cholangiocarcinoma
acquired vulnerability
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fonc.2022.1124912/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires